Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Vx Study Team"'
Publikováno v:
Journal of Cystic Fibrosis. 19:91-98
Background Ivacaftor shows benefit in patients with cystic fibrosis (CF) and CFTR mutations associated with residual CF transmembrane conductance regulator (CFTR) function. Here we further assess the effect of ivacaftor in such patients using an N-of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d56176074e42f608c8dd2c94293531f
https://doi.org/10.1016/j.jcf.2019.09.013
https://doi.org/10.1016/j.jcf.2019.09.013
